arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

BeOne Medicines Ltd.

ONC Health Care Biotechnology: Pharmaceutical Preparations
$358.26
Today
as of Sep 4, 16:52 ET
Last 30 days +8.41% Jul 28 → Sep 04
$308.72 $327.02 $345.31 $363.61 $381.91 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$359.71
High
$362.67
Low
$357.58
Volume
$201,833
Avg Vol
$287,220
Mkt Cap
$40.5B
P/E (TTM)
918.62
Beta
—
52w High
$385.22
52w Low
$253.95
Div Yield
—
Shares Out
$1.5B

Recent Press Releases & News last 60 days · 21 items

lean bull ▲ 3 ● 18 ▼ 0
Sep 5 · 03:09 Simply Wall St. neutral
The Bull Case For BeOne Medicines (ONC) Could Change Following US-Backed HER2 Regimen And Onshoring Deal
Sep 4 · 18:44 Insider Monkey neutral
BeOne (ONC) Secured a Pharmaceutical-Tariff Exemption After More than $1B of U.S. Manufacturing Investment. Are the Pricing Concessions Worth It?
Sep 1 · 17:01 REGULATORY Insider Monkey bullish
FDA Approval Marks A Turning Point For BeOne Medicines (ONC)
▸ Show all 21 press releases & news Free account →

Overview

52-week range
$254
$385
79% of range
Avg surprise (last 3)
+171.8%
Avg reaction (last 2)
+0.7%
50% positive
Latest IV / EM
33%
EM ±5.1% · $360 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.71$-0.04$0.62$1.29$1.96 Actual $-0.26Actual $-0.28Actual $0.15Actual $-0.19Actual $-0.09Actual $-0.09Actual $1.22Est $-0.71Actual $0.84Est $0.48Actual $0.08Actual $1.96Est $0.73Actual $0.16 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-121M$357M$834M$1.3B$1.8B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.16 — — — — financials
Wed May 6, 2026Mar/2026 $1.96 $0.73 +168.5% +60.7% +5.3% earnings
Tue Sep 30, 2025Sep 2025 $0.08 — — — — financials
Wed Aug 6, 2025Jun/2025 $0.84 $0.48 +75.0% — — earnings
Wed May 7, 2025Mar/2025 $1.22 $-0.71 +271.8% — -3.9% earnings
Mon Sep 30, 2024Sep 2024 $-0.09 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.09 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.19 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.15 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.28 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.26 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$1.71B$1.51B—$1.41B$1.32B$1.12B—$1.00B
Cost of revenue————————
Gross profit$1.53B$1.35B—$1.22B$1.15B$952M—$831M
Operating income$325M$250M—$163M$88M$11M—$-120M
Net income$237M$227M—$125M$94M$1M—$-121M
EPS (diluted)$0.16$0.15—$0.08$0.06——$-0.09

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$5.10B$4.79B$4.55B$4.04B$2.76B$2.52B$2.63B$2.70B
Inventory$733M$682M$608M$532M$503M$495M$495M$432M
Total current assets$7.22B$6.60B$6.23B$5.66B$4.31B$3.90B$3.99B$3.91B
Total assets$9.18B$8.55B$8.19B$7.63B$6.30B$5.84B$5.92B$5.83B
Long-term debt$882M$963M$962M—$146M$160M$166M$188M
Total liabilities$4.00B$3.79B$3.83B$3.50B$2.53B$2.34B$2.59B$2.39B
Total equity$5.17B$4.76B$4.36B$4.13B$3.77B$3.50B$3.33B$3.44B

Implied volatility — last 90 days

32%55%79%103%126% Jun 07 — IV 46% · EM ±6.3%Jun 08 — IV 43% · EM ±5.7%Jun 09 — IV 43% · EM ±5.4%Jun 10 — IV 48% · EM ±5.7%Jun 11 — IV 46% · EM ±5.1%Jun 12 — IV 44% · EM ±4.5%Jun 15 — IV 46% · EM ±3.3%Jun 16 — IV 65% · EM ±3.8%Jun 17 — IV 84% · EM ±3.5%Jun 19 — IV 40% · EM ±8.8%Jun 22 — IV 40% · EM ±8.4%Jun 23 — IV 42% · EM ±8.6%Jun 24 — IV 44% · EM ±8.8%Jun 25 — IV 42% · EM ±8.2%Jun 26 — IV 42% · EM ±8.0%Jun 29 — IV 41% · EM ±7.3%Jun 30 — IV 41% · EM ±7.1%Jul 01 — IV 42% · EM ±7.1%Jul 02 — IV 42% · EM ±6.7%Jul 03 — IV 43% · EM ±6.7%Jul 06 — IV 41% · EM ±5.7%Jul 07 — IV 41% · EM ±5.4%Jul 08 — IV 44% · EM ±5.5%Jul 09 — IV 41% · EM ±4.9%Jul 10 — IV 42% · EM ±4.6%Jul 13 — IV 50% · EM ±4.2%Jul 14 — IV 46% · EM ±3.3%Jul 15 — IV 45% · EM ±2.7%Jul 16 — IV 127% · EM ±5.3%Jul 20 — IV 46% · EM ±10.8%Jul 21 — IV 44% · EM ±10.1%Jul 22 — IV 44% · EM ±10.1%Jul 23 — IV 45% · EM ±10.1%Jul 24 — IV 44% · EM ±9.6%Jul 27 — IV 45% · EM ±9.4%Jul 28 — IV 47% · EM ±9.5%Jul 29 — IV 47% · EM ±9.4%Jul 30 — IV 46% · EM ±9.0%Jul 31 — IV 46% · EM ±8.9%Aug 03 — IV 49% · EM ±8.6%Aug 04 — IV 47% · EM ±8.1%Aug 05 — IV 39% · EM ±6.5%Aug 06 — IV 37% · EM ±5.9%Aug 07 — IV 37% · EM ±5.7%Aug 10 — IV 38% · EM ±5.3%Aug 11 — IV 39% · EM ±5.1%Aug 12 — IV 37% · EM ±4.7%Aug 13 — IV 38% · EM ±4.5%Aug 14 — IV 37% · EM ±4.1%Aug 17 — IV 43% · EM ±3.6%Aug 18 — IV 42% · EM ±3.0%Aug 19 — IV 47% · EM ±2.8%Aug 20 — IV 62% · EM ±2.6%Aug 24 — IV 35% · EM ±7.3%Aug 25 — IV 33% · EM ±6.8%Aug 26 — IV 34% · EM ±6.9%Aug 27 — IV 34% · EM ±6.6%Aug 28 — IV 33% · EM ±6.3%Aug 31 — IV 32% · EM ±5.7%Sep 01 — IV 32% · EM ±5.6%Sep 02 — IV 34% · EM ±5.7%Sep 03 — IV 35% · EM ±5.6%Sep 04 — IV 33% · EM ±5.1%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in